SNT ASX Chart
Snapshot
Syntara Limited (SNT, formerly Pharmaxis Ltd) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | +306.35% |
Announcements
Corporate Overview
Corporate Details
Head Office | Frenchs Forest NSW 2086 |
Website | www.syntaraTX.com.au |
Registry | BoardRoom |
Auditor | PricewaterhouseCoopers |
Date Listed | 10 Nov 2003 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Interim) |
29/07/2025 | Report (Quarterly) |
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
Former Company Names
- Pharmaxis Ltd (PXS), 07/12/2023
- Pharmaxis Limited PXS (11/11/2003)
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
SNT directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of SNT directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Biotechnology Value Fund, Inc | 14/09/2023 | 102,778,714 | 14.00 |
BVF Partners LP | 06/02/2024 | 201,488,850 | 16.92 |
D and A Income Limited | 19/12/2024 | 262,826,373 | 16.64 |
Platinum Investment Management Limited | 28/11/2024 | 189,403,942 | 13.79 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
19-12-24 | D and A Income Limited | 28,571,429 | 18.15 | 16.64 |
06-02-24 | Platinum Investment Management Limited | 174,349,738 | 7.63 | 19.24 |
06-02-24 | D and A Income Limited | 148,863,637 | 10.27 | 19.66 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
28-11-24 | Platinum Investment Management Limited | 14,948,173 | 14.9 | 13.8 |
18-10-24 | Platinum Investment Management Limited | 1,053,987 | 15.9 | 14.9 |
06-08-24 | Platinum Investment Management Limited | 10,454,316 | 18.1 | 15.9 |
12-04-24 | Platinum Investment Management Limited | 13,355,704 | 19.2 | 18.1 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.024 | 28 June |
2023 | $0.049 | 30 June |
2022 | $0.065 | 30 June |
2021 | $0.089 | 30 June |
2020 | $0.066 | 30 June |
2019 | $0.255 | 28 June |
2018 | $0.31 | 29 June |
2017 | $0.25 | 30 June |
2016 | $0.255 | 30 June |
2015 | $0.22 | 30 June |
2014 | $0.066 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.